What do docking and QSAR tell us about the design of HIV-1 reverse transcriptase nonnucleoside inhibitors?

Agata Paneth1,2, Wojciech Płonka3, Piotr Paneth4

  • 1Institute of Applied Radiation Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924, Łódź, Poland.